Medical Countermeasures

red and yellow background with scissors
Favicon Fierce Pharma

Narcan maker Emergent axes top R&D post in sweeping restructuring

In a bold move, Emergent will eliminate the role of head of R&D as part of a layoff round across all areas of the company.
Angus Liu Aug 5, 2026 8:16pm
Terminated contract

NIH nixes financing for Pluri's radiation exposure cell therapy

Apr 18, 2025 9:10am